Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors
about
Tumor Targeting and Drug Delivery by Anthrax ToxinAnthrax lethal and edema toxins in anthrax pathogenesisCytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins.Prodrug applications for targeted cancer therapy.Channel-forming bacterial toxins in biosensing and macromolecule deliveryAn anthrax toxin variant with an improved activity in tumor targetingTargeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden.Solid tumor therapy by selectively targeting stromal endothelial cells.The E. coli CNF1 as a pioneering therapy for the central nervous system diseases.Structural complementation of the catalytic domain of pseudomonas exotoxin AAnthrax lethal toxin rapidly reduces c-Jun levels by inhibiting c-Jun gene transcription and promoting c-Jun protein degradation.Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.Anti-tumor activity of anthrax toxin variants that form a functional translocation pore by intermolecular complementation.Functional classification of protein toxins as a basis for bioinformatic screening.Effect of endosomal acidification on small ion transport through the anthrax toxin PA63 channel.
P2860
Q26744720-3DFA3B2B-BBCF-40EB-919F-2ED825B41AB8Q26852034-A859FCD1-BF9C-40FC-93E6-1A8CA3915998Q33694949-D81747BB-4AC3-4E69-B04D-57F6117BB560Q34099780-06A2F31E-E511-417B-900A-799AF6F392DCQ34101821-17EA03AD-634C-42B0-A6E5-A91FA2CC9C89Q35846297-42884723-4C40-4C2C-913E-8F68335A50D1Q36545204-EF79F41A-2A9A-4946-8F14-3BEB104A0047Q37102436-2FB39E9C-6B6E-45DC-A94C-63143A89B168Q38176761-3A40C1AF-F1BF-4A56-AE26-F43FB90CB283Q38926270-7592064F-51AC-4CBD-BBF1-3E6B935AC955Q40052584-7D9C201B-986C-48A9-8652-D0CE41B46620Q42098191-58C89705-46FE-48ED-8100-6053FE454524Q42371508-B5419051-A17C-488F-8A0E-30EA52828BBBQ42637634-9F7A13A7-9AD7-486E-AEC4-714A6858D69DQ47722233-7B5FCB4B-E3F7-49B0-AB1A-D2CA9BA1283B
P2860
Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Engineering anthrax toxin vari ...... pplication to targeting tumors
@ast
Engineering anthrax toxin vari ...... pplication to targeting tumors
@en
Engineering anthrax toxin vari ...... pplication to targeting tumors
@nl
type
label
Engineering anthrax toxin vari ...... pplication to targeting tumors
@ast
Engineering anthrax toxin vari ...... pplication to targeting tumors
@en
Engineering anthrax toxin vari ...... pplication to targeting tumors
@nl
prefLabel
Engineering anthrax toxin vari ...... pplication to targeting tumors
@ast
Engineering anthrax toxin vari ...... pplication to targeting tumors
@en
Engineering anthrax toxin vari ...... pplication to targeting tumors
@nl
P2093
P2860
P50
P356
P1476
Engineering anthrax toxin vari ...... pplication to targeting tumors
@en
P2093
Alexander N Wein
Bryan T Hansen
Clinton E Leysath
Damilola D Phillips
Devorah Crown
Ekaterina M Nestorovich
Elizabeth R Fischer
Lacy Simons
Rasem J Fattah
Rodolfo Ghirlando
P2860
P304
P356
10.1074/JBC.M113.452110
P407
P577
2013-02-07T00:00:00Z